{"version":"1.0","provider_name":"Ren\u00e1lida","provider_url":"https:\/\/renalida.com\/en","author_name":"admin","author_url":"https:\/\/renalida.com\/en\/author\/renalida-dev\/","title":"Investigaciones - Ren\u00e1lida","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Ap5ibyOotK\"><a href=\"https:\/\/renalida.com\/en\/investigaciones-2\/\">Investigaciones<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/renalida.com\/en\/investigaciones-2\/embed\/#?secret=Ap5ibyOotK\" width=\"600\" height=\"338\" title=\"&#8220;Investigaciones&#8221; &#8212; Ren\u00e1lida\" data-secret=\"Ap5ibyOotK\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/renalida.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","description":"Transformando el futuro de la atenci\u00f3n renal \u00a0Entendemos que la nefrolog\u00eda enfrenta el desaf\u00edo de brindar respuestas eficaces en el tratamiento de las enfermedades renales, especialmente en sus fases predial\u00edticas. Este reto se refleja en la creciente incidencia de pacientes que progresan hacia la (ERC) terminal, con la consiguiente necesidad de di\u00e1lisis. Nuestro compromiso es [&hellip;]","thumbnail_url":"https:\/\/renalida.com\/wp-content\/uploads\/elementor\/thumbs\/ISN-ACT-qt1c0ts6sx8lbsdzru22v91mkgshagf3y8wy80depk.jpg"}